Intensity-modulated proton therapy decreases dose to organs at risk in low-grade glioma patients: results of a multicentric in silico ROCOCO trial

Daniëlle B. P. EekersDepartment of Radiation Oncology (MAASTRO), GROW – School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands; ;Proton Therapy Centre South-East Netherlands (ZON-PTC), Maastricht, The Netherlands; Correspondence[email protected]

Erik RoelofsDepartment of Radiation Oncology (MAASTRO), GROW – School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands; ;Department of Radiation Oncology (The D-Lab), GROW – School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands;

Macarena Cubillos-MesíasOncoRay – National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Cal Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany;

Charles NiëlDepartment of Radiation Oncology, Radiotherapiegroep, Deventer, The Netherlands;

Robert Jan SmeenkDepartment of Radiation Oncology, RadboudUMC, Nijmegen, The Netherlands;

Ann HoebenDepartment of Medical Oncology, GROW – School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands;

Andre W. H. MinkenDepartment of Radiation Oncology, Radiotherapiegroep, Deventer, The Netherlands;

Marlies GranzierDepartment of Radiation Oncology (MAASTRO), GROW – School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands;

Geert O. JanssensDepartment of Radiation Oncology, RadboudUMC, Nijmegen, The Netherlands; ;Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands; ;Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands;

Johannes H. A. M. KaandersDepartment of Radiation Oncology, RadboudUMC, Nijmegen, The Netherlands;

Philippe LambinDepartment of Radiation Oncology (The D-Lab), GROW – School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands;

Esther G. C. TroostOncoRay – National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Cal Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany; ;Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; ;Helmholtz-Zentrum Dresden – Rossendorf, Institute of Radiooncology – OncoRay, Dresden, Germany; ;German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany; ;National Center for Tumor Diseases (NCT) Partner Site Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, and Helmholtz Association/Helmholtz-Zentrum Dresden, Rossendorf (HZDR), Dresden, Germany

show all

Intensity-modulated proton therapy decreases dose to organs at risk in low-grade glioma patients: results of a multicentric in silico ROCOCO trial

Articles from other publishers (18)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Intensity-modulated proton therapy decreases dose to organs at risk in low-grade glioma patients: results of a multicentric in silico ROCOCO trial

Citations (18)

Articles from other publishers (18)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date